tradingkey.logo
tradingkey.logo
Pesquisar

Haemonetics Corp

HAE
Adicionar à lista de desejos
74.860USD
-0.140-0.19%
Fechamento 07/01, 16:00ETCotações atrasadas em 15 min
3.39BValor de mercado
36.30P/L TTM

Mais detalhes de Haemonetics Corp Empresa

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.

Informações de Haemonetics Corp

Código da empresaHAE
Nome da EmpresaHaemonetics Corp
Data de listagemOct 17, 1979
CEOSimon (Christopher A)
Número de funcionários3023
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 17
Endereço125 Summer Street
CidadeBOSTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal02110
Telefone17818487100
Sitehttps://www.haemonetics.com
Código da empresaHAE
Data de listagemOct 17, 1979
CEOSimon (Christopher A)

Executivos da empresa Haemonetics Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
40.07K
-0.78%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
34.51K
+10.58%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
--
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
--
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
-5.99%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
--
Mr. Michael J. Coyle
Mr. Michael J. Coyle
Independent Director
Independent Director
15.39K
--
Ms. Diane M. Bryant
Ms. Diane M. Bryant
Independent Director
Independent Director
7.13K
--
Mr. Roy Galvin
Mr. Roy Galvin
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
7.00K
+53.66%
Mr. Christopher A. Simon
Mr. Christopher A. Simon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
40.07K
-0.78%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
34.51K
+10.58%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
--
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
--
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
-5.99%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
--

Perguntas frequentes

Quem são os cinco principais acionistas de Haemonetics Corp?

Os cinco principais acionistas de Haemonetics Corp são: Ms. Laurie A. Miller

Quantas instituições possuem ações da Haemonetics Corp (HAE)?

Em 2026Q1, 737 instituições possuíam ações da Haemonetics Corp, com valor de mercado aproximado de 58.91M, representando 126.77% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 664078.00.